“We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but preliminary efficacy data as the study progresses,” said Dr. Huma Qamar, Chief ...
Age-related macular degeneration (AMD) is the leading cause of vision loss for people over 65. We have excellent treatments for the wet form of AMD. But until recently, we haven’t had any ...
and genetic therapies used in wet age-related macular degeneration (AMD). These therapies aid in overcoming problems with current therapies as well as tackling age-related diseases. Heart valves ...
The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration ... the way the "wet" form of AMD does. The percentage of people with dry AMD who lose their vision ...
Millions of people across the world suffer from dry and wet macular degeneration. Unfortunately, there’s no cure for it, though, there are some drugs that can sometimes improve the vision ...